Ampakines are a class of cognitive enhancers that work by targeting AMPA receptors in the brain, which are involved in the processes of learning and memory. They are known to increase the production and release of neurotransmitters such as glutamate, leading to improved cognitive function, including better memory, attention, and focus. Ampakines have been studied for their potential in treating various neurological disorders, including Alzheimer’s disease, depression, and schizophrenia. However, more research is needed to fully understand the safety and efficacy of ampakines, as well as their potential long-term effects on the brain.